Education
About Us
Working with TipRanks
Follow Us
Eric Crombez Insider Profile
4 Followers
Eric Crombez, CMO at Dimension Therapeutics Inc, holds ― shares in Dimension Therapeutics Inc (Ticker: DMTX), holds 71.92K shares in Ultragenyx Pharmaceutical (Ticker: RARE), holds 47.15K shares in Abeona Therapeutics (Ticker: ABEO). Most recently, Eric Crombez ― shares of Dimension Therapeutics Inc on ― for an estimated value of ―.
Profitable Transactions
2 out of 2 Profitable Transactions
Average Return
+9.20%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Eric Crombez holds in companies
Most Profitable Insider Trade
The most profitable trade made by Eric Crombez
Eric Crombez's Trading History
Dimension Therapeutics Inc
―
―
―
―
Ultragenyx Pharmaceutical
Mar 04, 2025
EVP and Chief Medical Officer
Uninformative Buy
―
$2.78M
Abeona Therapeutics
Feb 03, 2025
Director
Uninformative Buy
―
$243.27K
List of latest transactions for each holding click on a transaction to see Eric Crombez's performance on stock
You May Also Like
Eric Crombez insider profile FAQ
What is the percentage of profitable transactions made by Eric Crombez?
The percentage of profitable transactions made by Eric Crombez is 100%.
What is the average return per transaction made by Eric Crombez?
The average return per transaction made by Eric Crombez is 9.20%.
What stocks does Eric Crombez hold?
Eric Crombez holds: DMTX, RARE, ABEO stocks.
What was Eric Crombez’s latest transaction?
Eric Crombez latest transaction was an Uninformative Buy of ―.
What was Eric Crombez's most profitable transaction?
Eric Crombez’s most profitable transaction was an Informative Sell of RARE stock on May 3, 2024. The return on the trade was 9.60%.
What is Eric Crombez's role in Dimension Therapeutics Inc?
Eric Crombez's role in Dimension Therapeutics Inc is CMO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.